Viatris Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
8
Price Target
$12.00
Consensus
Neutral
Upside
0.25%
Analysts
5
Stock Rating
8
Upside
0.25%
Analysts
5
Price Target
$12.00

Viatris Inc Stock Forecast and Price Target

The average price target for Viatris Inc's stock of $12.00 recently provided by five leading analysts would represent a 0.25% upside from its last closing price if reached. This potential increase is based on a high estimate of $14.00 and a low estimate of $11.00. You may be interested in rivals even if you aren't interested in Viatris Inc stock.

$12.00

0.25% Upside

Hold
Hold

Viatris Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Viatris Inc's Price has fallen from $15.96 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $13.90, which would mean an increase of 100.00%. Over the next seven years, experts predict that Viatris Inc's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$13.90
2025 Fair Value Forecast
$14.02
2026 Fair Value Forecast
$14.71
2027 Fair Value Forecast
$15.55
2028 Fair Value Forecast
$16.00
2029 Fair Value Forecast
$16.40
2030 Fair Value Forecast
$16.77
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$734.37 Buy/Sell $636.99 10.71%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$161.23 Buy/Sell $174.55 5.44%
MRK Stock Forecast Merck Outperform 2
$122.77 Buy/Sell $130.51 9.96%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$54.36 Buy/Sell $58.15 1.18%

Viatris Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Viatris Inc's Revenue has grown by 29.14%, rising from $11.95B to $15.43B. For next year, analysts predict Revenue of $16.51B, which would mean an increase of 7.00%. Over the next seven years, experts predict that Viatris Inc's Revenue will grow at a rate of 10.85%.

2024 Rev Forecast
$16.51B
2025 Rev Forecast
$16.36B
2026 Rev Forecast
$17.11B
2027 Rev Forecast
$16.69B
2028 Rev Forecast
$16.82B
2029 Rev Forecast
$16.95B
2030 Rev Forecast
$17.10B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$414.47 Buy/Sell $457.59 8.57%
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$964.44 Buy/Sell $961.26 8.87%
ZTS Stock Forecast Zoetis Outperform 18
$183.49 Buy/Sell $220.47 20.72%

Viatris Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last year, Viatris Inc's Dividend per Share has grown by 6.67%, rising from $0.45 to $0.48. For next year, analysts predict Dividend per Share of $0.58, which would mean an increase of 20.83%. In 2030, professionals predict that Viatris Inc's Dividend per Share will decrease by 17.52%, to $0.40.

2024 DPS Forecast
$0.58
2025 DPS Forecast
$0.64
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.60
2028 DPS Forecast
$0.58
2029 DPS Forecast
$0.59
2030 DPS Forecast
$0.40
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAX Stock Forecast Baxter International Inc Outperform 17
$43.48 Buy/Sell $44.86 3.50%
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$149.10 Buy/Sell $245.24 44.20%
UTHR Stock Forecast United Therapeutics Outperform 12
$249.51 Buy/Sell $284.08 19.63%

Viatris Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$3.71B
2025 FCF Forecast
$3.46B
2026 FCF Forecast
$4.21B
2027 FCF Forecast
$3.69B
2028 FCF Forecast
$3.82B
2029 FCF Forecast
$4.01B
2030 FCF Forecast
$4.12B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CTLT Stock Forecast Catalent Hold 15
$56.81 Buy/Sell $49.29 11.78%
CYTK Stock Forecast Cytokinetics Outperform 10
$64.39 Buy/Sell $87.92 45.99%
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$43.26 Buy/Sell $55.60 41.01%

Viatris Inc EBITDA Forecast for 2023 - 2025 - 2030

Viatris Inc's EBITDA has grown In the last three years, rising from $2.66B to $3.67B – a growth of 38.07%. In the next year, analysts believe that EBITDA will reach $5.95B – an increase of 61.95%. For the next seven years, experts predict that Viatris Inc's EBITDA will grow at a rate of 95.74%.

2024 EBITDA Forecast
$5.95B
2025 EBITDA Forecast
$5.98B
2026 EBITDA Forecast
$6.28B
2027 EBITDA Forecast
$6.60B
2028 EBITDA Forecast
$6.78B
2029 EBITDA Forecast
$6.97B
2030 EBITDA Forecast
$7.19B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$260.15 Buy/Sell $315.92 29.16%
BCPC Stock Forecast Balchem Outperform 18
$156.04 Buy/Sell $145.00 4.46%
NEOG Stock Forecast Neogen Outperform 16
$16.19 Buy/Sell $37.00 17.36%

Viatris Inc EBIT Forecast for 2023 - 2025 - 2030

Viatris Inc's EBIT has seen impressive growth In the last three years, rising from $764.40M to $877.80M – a growth of 14.84%. In the next year, analysts believe that EBIT will reach $5.54B – an increase of 531.05%. For the next seven years, the forecast is for EBIT to grow by 620.63%.

2024 EBIT Forecast
$5.54B
2025 EBIT Forecast
$5.53B
2026 EBIT Forecast
$5.75B
2027 EBIT Forecast
$5.98B
2028 EBIT Forecast
$6.09B
2029 EBIT Forecast
$6.21B
2030 EBIT Forecast
$6.33B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$43.81 Buy/Sell $69.00 41.52%
TGTX Stock Forecast TG Therapeutics Outperform 9
$16.37 Buy/Sell $29.44 107.70%
CORT Stock Forecast Corcept Therapeutics Buy 16
$23.75 Buy/Sell $35.67 60.00%

Viatris Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Viatris Inc's EPS has fallen from $3.95 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $3.44, which would mean an increase of 100.00%. Over the next seven years, experts predict that Viatris Inc's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$3.44
2025 EPS Forecast
$3.47
2026 EPS Forecast
$3.64
2027 EPS Forecast
$3.85
2028 EPS Forecast
$3.96
2029 EPS Forecast
$4.06
2030 EPS Forecast
$4.15
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INDV Stock Forecast Indivior PLC Buy 14
£16.50 Buy/Sell £28.89 92.00%
IRWD Stock Forecast Ironwood Pharmaceuticals Buy 14
$8.95 Buy/Sell $17.83 95.53%
CPRX Stock Forecast Catalyst Pharmaceuticals Buy 16
$16.10 Buy/Sell $26.20 58.39%